Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders.
Research and Development
13 January 2019
Lundbeck is looking for a toxicologist with expertise in development of biological products to join the Department of Regulatory Toxicology & Safety Assessment.
The department consists of 12 employees and is situated in Valby, Denmark. The department has excellent facilities to perform rodent studies as well as complete clinical pathology and histopathology laboratories. The department is responsible for outsourcing all types of nonclinical safety studies to Contract Research Organizations (CROs) around the world and works closely together other departments within the nonclinical-, clinical-, pharmacology-, regulatory-, and pharmaceutical areas at Lundbeck. The department belongs to the Drug Safety Division under Non-Clinical Safety Research (NCSR). Our pipeline consists of both biological entities and small molecules.
You will be an important player in a department that participates in the full development process of pharmaceuticals from early research to post-marketing commitments. You will join cross-functional Global Project Teams (GPTs) as the non-clinical representative. As GPT member you will be leading the non-clinical project team responsible for all non-clinical safety activities in the project. Also, you will join the NCSR Biologics Team that oversees all biologics projects and participates in due diligences.
Our preferred candidate has a relevant educational background with a minimum of 10 years in non-clinical development of pharmaceuticals, with expert knowledge on biologics and experience in leading multidisciplinary teams. You have in-depth knowledge on immunology via education or training and you may have a background within the Pharmaceutical Industry or a CRO.
Please contact Head of Department, Allan Dahl Rasmussen by mail (email@example.com). We also recommend you to visit our website www.lundbeck.com.
Please click on the link below to apply for the job. Applications must be received no later than 13th January 2019.
Lundbeck is a global pharmaceutical company specialized in psychiatric and neurological disorders. For more than 70 years, we have been at the forefront of research within neuroscience. Our key areas of focus are depression, schizophrenia, Parkinson's disease and Alzheimer's disease.
An estimated 700 million people worldwide are living with psychiatric and neurological disorders and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with psychiatric and neurological disorders – we call this Progress in Mind.
Read more at www.lundbeck.com/global/about-us/progress-in-mind.
Our approximately 5,000 employees in more than 50 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more than 100 countries. Our research centre is based in Denmark and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 17.2 billion in 2017 (EUR 2.3 billion; USD 2.6 billion).
For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck and via our LinkedIn company page.
Become part of Lundbeck's professional network to stay up-to-date with our worldwide career opportunities.Go to LinkedIn
Stay updated with the latest news and conversations around Lundbeck and our business.Go to Twitter
Learn about our disease areas and hear stories by patients living with psychiatric and neurological disorders.Go to YouTube